Chest workout with dumbbells only 🔥

How to create bulletproof knees

Clinical inertia is tough. In-🏥 virtual consult #RCT for #CKM Intervention: ✅ expert #GDMTworks recs ✅ complete prior auths ✅ determine patient OOP💸 ✅ arrange post-🏥 f/u as needed Results: 🚫 No significant difference #SGLT2i prescription (PEP) https://t.co/CiSTzbDMgB

The most common chronic liver disease worldwide, metabolic dysfunction–associated steatotic liver disease (MASLD) affects approximately 30% to 40% of the general adult population. This Review summarizes the diagnosis, treatment, and prognosis of MASLD. https://t.co/uoIsEIV9aZ

Major Bleeding With Apixaban vs Aspirin A Subanalysis of the ARTESiA Randomized Clinical Trial Results of this subanalysis of the ARTESiA randomized clinical trial found that although the rate of major gastrointestinal bleeding was higher in patients with SCAF who were treated

Poland is emerging as a leader in Europe for effective lipid disorders management programmes—highlighting innovative strategies, improved diagnostics, and stronger care pathways across the country. 🔗 https://t.co/lbOUpO43cR #LipidManagement #CardioPrevention #EuropeHealth

Should P2Y12 inhibitor be preferred over aspirin for long treatment in ASCVD patients? https://t.co/cneG1rE1XI @DFCapodanno @vlgmrc @DLBHATTMD @CMichaelGibson @FeliceGragnano @Drroxmehran

A lower resting heart rate and higher heart rate variability (HRV) are generally indicative of better cardiovascular health 16-hour fasting raises HRV moderately and lowers resting heart rate compared to controls in 2 within-subject studies (each participant experiences both

Can Type 2 Diabetes Go Into Remission? - - - A new RCT says yes—at remarkable rates. 📊 Study (Zhang et al., 2025, BMC Medicine): Adults with obesity + newly diagnosed prediabetes/T2D were randomized to: 1️⃣ Standard meds + usual lifestyle advice 2️⃣ Weight-loss meds +

A new paper in #EHJ redefines endotypes of angina with non-obstructive coronary arteries. Read the results of prospective multicentre study 👉 https://t.co/8soSNZkPXb @RoccoMontone @ehj_ed

2026 ADA–EASD Consensus on Type 1 Diabetes in Adults 🔹 Diagnosis refined: No single test confirms T1D — combine clinical clues + islet antibodies + C-peptide. 5–10 % adults remain antibody-negative yet show autoimmune signatures. Always consider monogenic and ketosis-prone

Metabolic Dysfunction–Associated Steatotic Liver Disease in AdultsA Review 🌍 MASLD affects up to 40% of adults and up to 70–80% of people with obesity or t2 diabetes. ⚕️ Diagnosis:Ultrasound or non-invasive fibrosis scores (like FIB-4, elastography). 🏃‍♀️ Treatment:Weight loss,

🚨 New publication alert 🙌Our last manuscript is published in @ATHjournal : “Lipid-Lowering Therapies in Chronic Kidney Disease: A Call to Action.” 👉Key highlights: 1⃣CKD is a major and independent risk factor for ASCVD. 2⃣CKD patients are still underrepresented in LLT

🩺 MASH is closely linked to cardiometabolic disease, especially T2 diabetes and obesity Awareness remains low outside hepatology. 🇨🇦 In Canada, limited diagnostics and (until recently) no national guidelines have hindered care. 👉 This review proposes Cross-disciplinary

☝️Overall, the risk/benefit ratio argues in favour of intensive LDL-C lowering despite the risk of increasing diabetes by shifting glucose levels above a biochemical threshold. https://t.co/92rtfBO64Z

Hypertension: Initial management For patients with stage 1 hypertension (i.e., systolic pressure 130–139 mmHg and/or diastolic pressure 80–89 mmHg) who have low overall risk for cardiovascular disease events, initial therapy should be lifestyle interventions. If goal blood

Master metabolism with 9 steps/arrows Here’s my shortcut to remembering it in just 9️⃣ arrows: 1️⃣ Glu → Fru → Pyr (Glucose → Fructose → Pyruvate) This is glycolysis — the breakdown of glucose into pyruvate for quick energy. 💡 Example: Eat bread, glucose enters your cells,

Our Scientific Statement on Non-adherence in heart failure 💔 Heart failure affects >60 million people worldwide Many don’t receive the full benefit of modern therapies due to medication non-adherence. 🔬 A new scientific statement highlights the urgent need for system-wide

https://t.co/RahWT55BJq

Beyond LDL Cholesterol Reduction: Pleiotropic Profiling of Statins. https://t.co/elfy8yadm7 @anymzcs @LipidoSeen @preventiva_SEC @almucastro01 @gt_rcv @drshafikuchay